REGADO BIOSCIENCES INC

Profile

Company Names

REGADO BIOSCIENCES INC

Addresses

120 MOUNTAIN VIEW BOULEVARD, BASKING RIDGE, NJ 07920

Phone Numbers

908.580.2111

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$127,164,664.00

Number of Funding Rounds:

6
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
6
2014-02-05 
$20,000,000.00 
$20,000,000.00 
$0.00 
Equity 
5
2012-12-18 
$22,634,958.00 
$50,780,221.00 
$28,145,263.00 
Equity 
4
2012-05-03 
$6,780,540.00 
$13,561,080.00 
$6,780,540.00 
Equity, Debt 
3
2011-05-25 
$11,599,999.00 
$11,599,999.00 
$0.00 
Equity 
2
2010-03-30 
$40,000,000.00 
$40,000,000.00 
$0.00 
Equity 
1
2009-12-17 
$26,149,167.00 
$26,149,167.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
B. 
JEFFERSON 
CLARK 
DIRECTOR
HYPERBRANCH MEDICAL TECHNOLOGY INC   |  ALDAGEN INC   |  ARGOS THERAPEUTICS INC   |  REGADO BIOSCIENCES INC   |  METABOLON, INC   |  ESSENTIAL HEALTH SOLUTIONS INC.   |  VERITAS COLLABORATIVE HOLDINGS, LLC   |  CUREATE, LLC   |  MATCHWELL, LLC   |  MATCHWELL, INC.   |  QUINSITE, INC.   |  GALAXY DIAGNOSTICS, INC.   |  PNEUMOCYTE LLC
JEFF 
 
CLARK 
DIRECTOR
CARDIOXYL PHARMACEUTICALS INC   |  REGADO BIOSCIENCES INC   |  NOVOCOR MEDICAL SYSTEMS, INC.   |  CARLSBAD FITNESS GROUP LLC   |  JAMACHA HOLDINGS LLC   |  FITNESS FINANCE LLC   |  VENTURE FIT LLC   |  FLOOREXPO INC   |  LADERX, LLC   |  TENDONOVA CORP   |  PHINITE INC.   |  DEALER ALCHEMIST, INC.
CHRIS 
 
COURTS 
EXECUTIVE OFFICER
REGADO BIOSCIENCES INC
ANTON 
 
GOPKA 
DIRECTOR
CODA THERAPEUTICS INC   |  MARINUS PHARMACEUTICALS INC   |  REGADO BIOSCIENCES INC
PIERRE 
 
LEGAULT 
DIRECTOR
REGADO BIOSCIENCES INC   |  NEPHROGENEX, INC.   |  BICYCLE THERAPEUTICS PLC
DAVID 
J 
MAZZO 
EXECUTIVE OFFICER, DIRECTOR
REGADO BIOSCIENCES INC
DAVID 
J. 
MAZZO 
EXECUTIVE OFFICER, DIRECTOR
REGADO BIOSCIENCES INC   |  CALADRIUS BIOSCIENCES, INC.
MICHAEL 
 
MENDELSOHN 
DIRECTOR
REGADO BIOSCIENCES INC   |  CARDURION PHARMACEUTICALS, LLC   |  CYCLERION THERAPEUTICS, INC.   |  CARDURION PHARMACEUTICALS, INC.
MICHAEL 
 
METZGER 
EXECUTIVE OFFICER
PAYSCALE INC   |  MERSANA THERAPEUTICS INC   |  REGADO BIOSCIENCES INC   |  PAYSCALE HOLDINGS, INC.   |  SYNDAX PHARMACEUTICALS INC   |  TARVEDA THERAPEUTICS, INC.   |  HEADSET, INC.
P. 
SHERRILL 
NEFF 
DIRECTOR
REGADO BIOSCIENCES INC   |  BIOLEX THERAPEUTICS, INC.   |  RAINDANCE TECHNOLOGIES INC   |  INTACT VASCULAR, INC.   |  NEURONETICS, INC.   |  VESPER MEDICAL, INC.   |  RAPID MICRO BIOSYSTEMS, INC.
DENNIS 
 
PODLESAK 
EXECUTIVE OFFICER, DIRECTOR
CORTHERA INC   |  REGADO BIOSCIENCES INC   |  SYNDAX PHARMACEUTICALS INC   |  ADYNXX INC   |  KALIDEX PHARMACEUTICALS, INC.   |  RIGHTCARE SOLUTIONS, INC.   |  ADYNXX, INC.   |  ADASTRA PHARMACEUTICALS, INC.   |  EXALYS THERAPEUTICS, INC.   |  TRANSPOSON THERAPEUTICS, INC.
DENNIS 
J. 
PODLESAK 
EXECUTIVE OFFICER, DIRECTOR
REGADO BIOSCIENCES INC
JESSE 
 
TREU 
DIRECTOR
TANDEM DIABETES CARE INC   |  AFFERENT PHARMACEUTICALS, INC.   |  REGADO BIOSCIENCES INC   |  VERACYTE, INC.   |  ALTEA THERAPEUTICS CORP   |  RIGHTCARE SOLUTIONS, INC.   |  SEBACIA, INC.
RAPHAEL 
 
WISHIEWSKI 
DIRECTOR
REGADO BIOSCIENCES INC
RAPHAEL 
 
WISNIEWSKI 
DIRECTOR
REGADO BIOSCIENCES INC   |  AXONICS MODULATION TECHNOLOGIES, INC.   |  CHASE PHARMACEUTICALS CORP   |  BIOVENTRIX INC
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2014-02-25
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2014-02-05 
2013-01-17
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-12-18 
2012-05-21
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2012-05-03 
2011-07-01
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-03-30 
2011-07-01
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-05-25 
2011-06-30
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2009-12-17 
2010-01-05
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2009-12-17 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
COWEN AND COMPANY, LLC
7616
NONE
NONE
BMO CAPITAL MARKETS CORP.
16686